18
Participants
Start Date
July 10, 2019
Primary Completion Date
February 4, 2021
Study Completion Date
February 4, 2021
Q-Griffithsin (Q-GRFT) enema
Investigational enema composed of 4.2mL Q-Griffithsin (Q-GRFT) 9.6mg/mL combined with approximately 120.8mL of 0.9% sodium chloride solution to yield an active enema study product that will contain and deliver a dose of approximately 40mg of Q-GRFT
Placebo enema
Approximately 125mL of 0.9% sodium chloride solution
HIV/AIDS Clinical Research Unit / University of Pittsburgh, Pittsburgh
Collaborators (1)
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Intrucept Biomedicine LLC
UNKNOWN
Rhonda Brand
OTHER